Metabolic coupling in phyllodes tumor of the breast and its association with tumor progression
- Nah Ihm Kim
- Min Ho Park
- Sun-Seog Kweon
- Ji Shin Lee
Affiliations: Department of Pathology, Chonnam National University Medical School, Gwangju 61469, Republic of Korea, Department of Surgery, Chonnam National University Medical School, Gwangju 61469, Republic of Korea, Department of Preventive Medicine, Chonnam National University Medical School, Gwangju 61469, Republic of Korea
- Published online on: November 3, 2023 https://doi.org/10.3892/ol.2023.14132
Copyright: © Kim
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
There are markers of metabolic coupling in breast cancer. Loss of caveolin‑1 (Cav‑1) and upregulation of monocarboxylate transporters (MCTs), especially MCT1 and MCT4, serve an important role in metabolic coupling necessary for release and uptake of metabolites. However, the occurrence of these phenomena in phyllodes tumors (PTs) of the breast is unclear. A total of 101 PTs (60 benign, 26 borderline and 15 malignant) and nine breast tissue samples with no pathological lesions were analyzed. Immunohistochemical staining for Cav‑1, MCT1 and MCT4 was performed using tissue microarray and their expression in both stromal and epithelial components was assessed. Cav‑1 expression in PTs demonstrated a significant decrease in the stromal component compared with that in the normal breast tissues (P<0.001). MCT1 expression in both epithelial and stromal components was significantly increased in PTs, compared with that in normal breast tissues (both P<0.001). Stromal MCT1 and MCT4 expression were different depending on tumor grade of PTs, and stromal MCT1 expression significantly increased with increasing tumor grade (P<0.001). Although not statistically significant, stromal Cav‑1 expression notably decreased with increases in PT grade. High stromal MCT1 expression was significantly associated with lower disease‑free survival rate in comparison with low stromal MCT1 expression (P<0.05). These results suggested that changes in protein expression of Cav‑1, MCT1 and MCT4 may be associated with tumorigenesis and progression of PTs of the breast.